Form D · Biotechnology
PARTURA Medical, Inc.
Seattle, WA · CIK 0001701248
Offering snapshot reported Jul 7, 2017 · SEC filing
- Reported sold
- $280K Offering amount: $350K
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Jul 5, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 7, 2017 | Initial | $280,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-290202
Source: Form D, filed Jul 7, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Eric Heinberg | Director, Executive |
| Eric Sokol | Director, Executive |
| John Sullivan | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2020 S. Charles St.
Seattle, WA, 98144
Seattle, WA, 98144